118 related articles for article (PubMed ID: 23785795)
1. [Establishment of novel biomarkers for Personalized medication for atopic dermatitis].
Ohta S; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Masuoka M; Izuhara K
Rinsho Byori; 2013 Mar; 61(3):247-55. PubMed ID: 23785795
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis.
Ohta S; Shibata R; Nakao Y; Azuma Y; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Iwasaka T; Izuhara K
Ann Clin Biochem; 2012 May; 49(Pt 3):277-84. PubMed ID: 22402915
[TBL] [Abstract][Full Text] [Related]
3. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of a diagnostic system for allergic diseases aiming at personalized medicine--establishment of a novel ELISA system for SCCA].
Ohta S; Azuma Y; Shiraishi H; Noguchi Y; Izuhara K
Rinsho Byori; 2008 Nov; 56(11):980-5. PubMed ID: 19086453
[TBL] [Abstract][Full Text] [Related]
5. Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohort.
Takeuchi S; Furusyo N; Ono J; Azuma Y; Takemura M; Esaki H; Yamamura K; Mitamura Y; Tsuji G; Kiyomatsu-Oda M; Hayashi J; Izuhara K; Furue M
J Dermatol Sci; 2019 Aug; 95(2):70-75. PubMed ID: 31378660
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients.
Okawa T; Yamaguchi Y; Kou K; Ono J; Azuma Y; Komitsu N; Inoue Y; Kohno M; Matsukura S; Kambara T; Ohta S; Izuhara K; Aihara M
Allergol Int; 2018 Jan; 67(1):124-130. PubMed ID: 28734739
[TBL] [Abstract][Full Text] [Related]
7. Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases.
Izuhara K; Yamaguchi Y; Ohta S; Nunomura S; Nanri Y; Azuma Y; Nomura N; Noguchi Y; Aihara M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642409
[TBL] [Abstract][Full Text] [Related]
8. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigens are sensitive biomarkers for atopic dermatitis in children and adolescents: a cross-sectional study.
Hirayama J; Fujisawa T; Nagao M; Kuwabara Y; Kainuma K; Azuma Y; Ono J; Ohta S; Hirayama M; Izuhara K
Asia Pac Allergy; 2021 Oct; 11(4):e42. PubMed ID: 34786372
[TBL] [Abstract][Full Text] [Related]
10. [Search of a novel diagnostic marker for allergic diseases by the microarray approach].
Izuhara K
Rinsho Byori; 2006 Jul; 54(7):738-43. PubMed ID: 16913665
[TBL] [Abstract][Full Text] [Related]
11. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
12. An association of periostin levels with the severity and chronicity of atopic dermatitis in children.
Sung M; Lee KS; Ha EG; Lee SJ; Kim MA; Lee SW; Jee HM; Sheen YH; Jung YH; Han MY
Pediatr Allergy Immunol; 2017 Sep; 28(6):543-550. PubMed ID: 28631851
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
14. Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis.
Ott H; Wilke J; Baron JM; Höger PH; Fölster-Holst R
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):395-402. PubMed ID: 19744181
[TBL] [Abstract][Full Text] [Related]
15. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
Jenerowicz D; Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
[TBL] [Abstract][Full Text] [Related]
16. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring.
Ezzat MH; Hasan ZE; Shaheen KY
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):334-9. PubMed ID: 21294778
[TBL] [Abstract][Full Text] [Related]
17. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
18. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
19. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
20. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
